key: cord-1005922-lve4xnik authors: Lim, Liangzhong; Dang, Mei; Roy, Amrita; Kang, Jian; Song, Jianxing title: Curcumin Allosterically Inhibits the Dengue NS2B-NS3 Protease by Disrupting Its Active Conformation date: 2020-09-29 journal: ACS Omega DOI: 10.1021/acsomega.0c00039 sha: c70a1404dee91e0c2b5f65c2c79007204a9f521d doc_id: 1005922 cord_uid: lve4xnik [Image: see text] Flaviviruses including dengue virus and Zika virus encode a unique two-component NS2B-NS3 protease essential for maturation/infectivity, thus representing a key target for designing antiflavivirus drugs. Here, for the first time, by NMR and molecular docking, we reveal that curcumin allosterically inhibits the dengue protease by binding to a cavity with no overlap with the active site. Further molecular dynamics simulations decode that the binding of curcumin leads to unfolding/displacing the characteristic β-hairpin of the C-terminal NS2B and consequently disrupting the closed (active) conformation of the protease. Our study identified a cavity most likely conserved in all flaviviral NS2B-NS3 proteases, which could thus serve as a therapeutic target for the discovery/design of small-molecule allosteric inhibitors. Moreover, as curcumin has been used as a food additive for thousands of years in many counties, it can be directly utilized to fight the flaviviral infections and as a promising starting for further design of potent allosteric inhibitors. Dengue virus (DENV) of the Flaviviridae family, which also includes several other human pathogens such as Zika virus (ZIKV), West Nile virus, Japanese encephalitis and yellow fever viruses, is the most prevalent human pathogens transmitted by Aedes mosquitoes with 3.6 billion people at risk, particularly in tropical and subtropical regions. Annually over 390 million human infections occur in ∼110 countries including the southern US and Singapore, which leads to ∼25,000 deaths mostly among children. 1−4 DENV causes dengue fever, dengue haemorrhagic fever, and dengue shock syndrome. Despite intense studies, so far, no marketed antiviral drug exists to effectively treat dengue associated diseases. 4−6 The DENV genome is composed of an 11-kb singlestranded positive sense RNA, which is translated into a large polyprotein by the host-cell machinery upon infection. The polyprotein of the Flaviviridae family needs to be subsequently processed into 10 proteins, which include three structural proteins (capsid, membrane, and envelope) and seven nonstructural proteins (NS1, NS2A/B, NS3, NS4A/B, and NS5). The structural proteins constitute the viral particle while the nonstructural proteins are involved in the replication of the RNA genome, virion assembly, and attenuation of the host antiviral response, thus essential for replication of all flaviviruses. The correct processing of the polyprotein is implemented by host cell proteases including furin and signalaseas, as well as a virus-encoded NS2B-NS3 protease, which thus has been established as a valuable target for drug design to treat DENV and other flavivirus infections. 4−24 The dengue protease domain consists of the N-terminal part of the NS3 protein adopts a chymotrypsin-like fold consisting of two β-barrels, each composed of six β-strands, with the catalytic triad (His51-Asp75-Ser135) located at the cleft between the two β-barrels ( Figure 1A ). Unlike other proteases with a chymotrypsin-like fold, the flavivirus proteases including dengue one, additionally require a stretch of ∼40 amino acids from the cytosolic domain of NS2B for its catalytic function, thus called a two-component protease. While the protease domains adopt highly similar structures in all crystal structures, the NS2B cofactor was found to assume two distinctive structures, namely, the inactive or open form in the unbound state (I of Figure 1A ) as well as active or closed form in complex with the substrate peptide (II of Figure 1A ) by X-ray crystallography. 8−11 Furthermore, recent NMR studies revealed that in solution, the dengue NS2B-NS3 protease is very dynamic and undergoes the exchange between two conformations. However, the closed conformation is the major form even in the unbound state, which thus represents the best model for structure-guided drug designs. 12−15 Previous efforts for drug development targeting the flaviviral NS2B-NS3 proteases revealed the major challenge in rational design of their active site inhibitors: their active sites are relatively flat. 9−24 In this context, to respond to the urgency to fight ZIKV and DENV infection in Singapore, previously we conducted an intense attempt to screen inhibitors for the Zika and dengue NS2B-NS3 proteases from natural products isolated from edible plants. We successfully identified a natural phenol curcumin, or 1,7-bis(4-hydroxy-3 methoxyphenyl)-1,6heptadiene-3,5-dione ( Figure 1B) , with a significant inhibitory effect on both proteases. 21 Further analysis of enzymatic kinetics revealed that curcumin inhibits the Zika NS2B-NS3 protease in a noncompetitive mode. In other words, Curcumin may act as an allosteric inhibitor for the NS2B-NS3 proteases. Curcumin is of both fundamental and therapeutic interest because it has a significant inhibitory effect on the Zika NS2B-NS3 protease (IC 50 of 3.45 μM and K i of 2.61 μM) as we previously determined. 21 Very recently, curcumin and its four analogues were also found to inhibit the dengue NS2B-NS3 protease as well as replicon replication in DENV-infected cells. 4 Moreover, curcumin is isolated from a very popular food additive yellow ginger turmeric (Curcuma longa). A huge number of previous studies have shown that curcumin owns a diversified biological and pharmaceutical activities. Including antitumoral, antimicrobial, anti-inflammatory, antioxidant, antihepatotoxic, antihyperlipidemic, antiviral, and anti-Alzheimer's disease effects. 4,25−27 In this study, we aimed to understand the mechanism by which curcumin inhibits the dengue NS2B-NS3 protease with biochemical assay and biophysical methods including NMR spectroscopy and molecular dynamics (MD) simulations. For the first time, our NMR studies reveal that in contrast to the active-site inhibitors which act to reduce the dynamics of the dengue NS2B-NS3 protease, 15 curcumin significantly increased the backbone dynamics of the dengue protease particularly on μs to ms time scale. Nevertheless, we have successfully established the binding mode as derived from the NMRderived constraints, showing that curcumin binds to a cavity of the dengue NS2B-NS3 protease which has no overlap with its active site. Further MD simulations reveal that the binding of curcumin leads to the disruption of the closed conformation which is essential for its catalytic activities. Altogether, our study provides a dynamic view of the mechanism by which curcumin allosterically inhibit the dengue NS2B-NS3 protease through mediating the equilibrium between the open and closed conformations. Therefore, the modulation of this conformational equilibrium might indeed represent a promising strategy to discover/design small molecules for allosterically inhibiting the flaviviral NS2B-NS3 proteases to treat flavivirus infections. Previous studies have extensively shown that the dengue NS2B-NS3 protease with the NS2B and NS3 covalently unlinked better represents the in vivo state, and also manifested well-dispersed NMR spectra which thus allowed the NMR assignment. 14, 16 As such, in the present study we used the same unlinked version of the dengue NS2B-NS3 protease we previously constructed 16 for all experiments. We determined its K m to be 89.39 ± 6.62 μM; and K cat to be 0.12 ± 0.01 s −1 , which are almost identical to our previous results with K m = 92.39 ± 9.94 μM and K cat = 0.15 ± 0.01 s −1 . 16 In our previous screening, we found that curcumin also showed significant inhibitory effect on the dengue NS2B-NS3 protease. Here, we further determined its value of IC 50 to be 7.18 ± 0.62 μM and inhibitory constant K i to be 4.35 ± 0.02 μM ( Figure 1B ), which are only slightly different from those on the Zika NS2B-NS3 protease (IC 50 of 3.45 μM and K i of 2.61 μM). As we previously observed on the Zika NS2B-NS3 protease, 21 curcumin also inhibited the dengue NS2B-NS3 protease by changing V max but not K m (II of Figure 1B ), thus indicating that curcumin also acts as a noncompetitive inhibitor for the dengue NS2B-NS3 protease. 2.2. NMR Characterization of the Binding of Curcumin to the Dengue Protease. To gain insights into the binding mode of curcumin to the dengue NS2B-NS3 protease, we have successfully obtained the protease samples with either the NS2B cofactor or NS3 protease domain selectively 15 N-labeled. In the NS2B-NS3 protease complex, both 15 N-labeled NS2B (Figuure S1A) and NS3 protease domain ( Figure S1B ) have well-dispersed heteronuclear single quantum correlation (HSQC) spectra, typical of the wellfolded protein. Furthermore, the chemical shifts of their HSQC peaks are very similar to what were previously assigned. 14, 16 Very unexpectedly, however, when we titrated the dengue protease samples with curcumin at molar ratios of 1:0.5, 1:1; 1:2.5, 1:5 and 1:10 (protease/curcumin), no significant shifts were observed for most HSQC peaks of both NS2B ( Figure S1A ) and NS3 protease domain ( Figure S1B ), indicating that the binding did not induce significant structural changes. On the other hand, the HSQC peaks became step-wise broad and consequently their intensity gradually reduced. At 1:10, many well-dispersed HSQC peaks became too weak to be detectable. Usually, the line-broadening of HSQC peaks upon binding results from the micromolar dissociation constants, and/or binding-induced increase of conformational exchanges particularly on μs to ms time scale. 12−16,28−31 For example, previously we found that the binding of small molecules to EphA4 receptor with micromolar K d led to significant broadening of EphA4 HSQC peaks. 28, 29 Furthermore, for a well-folded protein, a slight disruption/destabilization of the native structure was sufficient to trigger the significant increase of conformational exchange on μs to ms time scale with many well-dispersed HSQC peaks broadened/disappeared. 30, 31 Here, the curcumin binding-provoked increase of conforma-tional exchanges might explain the fact that our isothermal titration calorimetry measurements of the binding of curcumin to the dengue NS2B-NS3 all gave rise to the data with a very high level of noises. The current results indicate that the binding of curcumin would lead to significant increase of dynamics particularly on μs to ms time scale, which is in a sharp contrast to a recent NMR study of the interaction of the dengue NS2B-NS3 protease with an active-site inhibitor, in which the inhibitor binding led to a significantly reduced dynamics, thus manifesting high-quality NMR spectra. 15 Consequently, here, because of the significant weakening of the intensity of HSQC peaks of the dengue NS2B-NS3 protease upon binding to curcumin, despite intense attempts we were unable to acquire high-quality NMR relaxation data to derive the backbone dynamics of the protease bound to curcumin as we previously performed on other proteins on ps to ns and μs to ms time scales. 29, 30 2.3. NMR-Guided Molecular Docking of the Curcumin-Binding Mode. Because of the significant increase of the protease dynamics upon binding to curcumin which led to severe NMR line broadening, we were also unable to further determine the structure of the protease complex with curcumin by NMR spectroscopy. Furthermore, we also intensely attempted to crystalize the complex sample by screening a large array of buffer conditions but all failed. Therefore, here we analyzed the intensity of HSQC peaks in the presence of curcumin at different molar ratios, and Figure 2 shows the normalized intensity of the NS2B ( Figure 2A ) and NS3 protease domain ( Figure 2B ) in the presence of curcumin at 1:5. The NS2B has an average intensity of 0.63 while the NS3 protease domain has an average intensity of 0.76, implying that slightly more dynamics were provoked on the NS2B cofactor than on the NS3 protease domain. Noticeably, some residues have significantly reduced HSQC peak intensity (93%. Stock solution of curcumin was dissolved in DMSO. The protease is in 50 mM Tris-HCl (pH 7.5), 0.001% Triton X-100, 0.5 mM EGTA at 37°C. To determine IC 50 for curcumin, 50 nM protease was incubated with various concentrations of curcumin (in 1 μL DMSO) at 37°C for 30 min, and Bz-nKRR-AMC addition to 250 μM initiated enzymatic reaction. To determine K i for curcumin, the same kinetic assay was performed with different final concentration of Bz-nKRR-AMC and curcumin. Enzymatic reaction was monitored with fluorescence upon hydrolysis of substrate peptide (Bz-nKRR-AMC) at λ ex of 380 nm and λ em of 450 nm. Fluorescence values (relative fluorescence units/s) were fitted to the noncompetitive inhibition model in GraphPad Prism 7.0; K i was obtained with fitting to equation: V maxinh = V max /(1 + I/K i ), while I is the concentration of inhibitor. 16 10 and in the open conformation (PDB ID of 4M9T) 18 were used for docking. Chemical structure of curcumin was downloaded from ChemicalBook database (http://www. chemicalbook.com), and their structural geometry were generated and optimized with Avogadro. 47 NMR titration derived constraints were used to guide the docking by HADDOCK software 32 and CNS. 48 CNS topology and force field parameters of curcumin is converted from PRODRG server. 49 The docking of the curcumin-protease complex was performed in three stages: (1) randomization and rigid body docking; (2) semi-flexible simulated annealing; and (3) flexible explicit solvent refinement, as we extensively performed. 33, 34 The complex structures with the lowest energy score were selected for the detailed analysis and display by Pymol (PyMOL Molecular Graphics System, version 0.99rc6 Schrodinger, LLC). 4.5. MD Simulations. The crystal structure of the dengue NS2B-NS3 protease (PDB code: 3U1I) in the closed conformation was used as the unbound form while the docking structure of the curcumin-protease complex with the lowest energy was used as the bound form in the current MD simulations with three independent simulations for each of them. Electrostatic potential of both curcumin was first calculated with the 6-31G(d,p) basis set using the Gaussian 16 program, which is converted into partial charge of individual atoms using restrained electrostatic potential procedure in Antechamber program. 50 The topology parameters of curcumin were obtained using GAFF. 51 All MD simulations reaching 50 ns were conducted using GRO-MACS, 52 and AMBER99SB-IDLN all-atom force field 53 parameters. The simulation system is a periodic cubic box with a minimum distance of 12 AÅ between the protein and the box walls to ensure the proteases does not interact with its own periodic images during MD simulation. About 13,000 water molecules (TIP3P model) solvated the cubic box for the all atom MD simulation. 2 Na + ions were randomly placed to neutralize the charge of protein complex. The long-range electrostatic interactions were treated using the fast particlemesh Ewald summation method. 54 The time step was set as 2 fs. All bond lengths including hydrogen atoms were constrained by the LINCS algorithm. 55 Prior to MD simulations, the initial structures were relaxed by 500 steps of energy minimization, followed by 100 ps equilibration with a harmonic restraint potential. 4.6. Correlation Analysis. To analyze correlated motions for residues of the complex, we utilize mutual information (MutInf) approach, which calculates correlated motion between pairs of residues using low-frequency motions (internal coordinates) that are represented by dihedral angles. 56 The approach here uses internal coordinates of different protein conformers obtained from MD simulations, and converts them into configurational entropy expansion terms which are computed in an entropy-based correlation matrix. The degree of correlated motions between different pairs of residues with correlated conformations is represented by a metric called MutInf. 56 In this present study, we first normalized MutInf values and 0.55 was were used as the threshold value to define pairs of residues as highly correlated motions. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.0c00039. NMR spectra of the dengue NS2B-NS3 protease free and bound to curcumin and correlated motion maps of the dengue NS2B-NS3 protease free and bound to curcumin (PDF) Asia-Pacific and Americas Dengue Prevention Boards Surveillance Working Group. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards The global distribution and burden of dengue Dengue: a continuing global threat Inhibition of dengue virus by curcuminoids The Medicinal Chemistry of Dengue Virus Progress and prospects on DENV protease inhibitors Structural proteomics of dengue virus Structural biology of dengue virus enzymes: towards rational design of therapeutics Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus Ligand-bound structures of the dengue virus protease reveal the active conformation protease helicase as a target for antiviral drug development Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex Inhibitor Bound Dengue NS2B-NS3pro Reveals Multiple Dynamic Binding Modes NMR and MD studies reveal that the isolated dengue NS3 protease is an intrinsically disordered chymotrypsin fold which absolutely requests NS2B for correct folding and functional dynamics Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetra-peptide and octapeptide substrate libraries Allosteric inhibition of the NS2B-NS3 protease from dengue virus ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants Exploiting the unique features of Zika and Dengue proteases for inhibitor design Structurally-and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, Dengue and Zika viruses Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity Dynamic principle for designing antagonistic/agonistic molecules for EphA4 receptor, the only known ALS modifier TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA Molecular mechanism underlying the thermal stability and pH-induced unfolding of CHABII HADDOCK: a protein-protein docking approach based on biochemical or biophysical information Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor ATP binds and inhibits the neurodegeneration-associated fibrillization of the FUS RRM domain Dynamics of proteins: elements and function Enzyme dynamics point to stepwise conformational selection in catalysis Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding Dynamically-driven inactivation of the catalytic machinery of the SARS 3C-like protease by the N214A mutation on the extra domain Dynamically-driven enhancement of the catalytic machinery of the SARS 3C-like protease by the S284-T285-I286/A mutations on the extra domain Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists De novo discovery of nonstandard macrocyclic peptides as noncompetitive inhibitors of the Zika virus NS2B-NS3 protease Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease Bioavailability of curcumin: problems and promises How to measure and predict the molar absorption coefficient of a protein Crystallography & NMR system: A new software suite for macromolecular structure determination PRODRG: a tool for high-throughput crystallography of protein−ligand complexes A wellbehaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model Development and testing of a general amber force field GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation Improved side-chain torsion potentials for the Amber ff99SB protein force field A smooth particle mesh Ewald method LINCS: a linear constraint solver for molecular simulations Quantifying correlations between allosteric sites in thermodynamic ensembles